OBJECTIVE The L-type Ca 2ϩ current (I Ca,L ) and the Na ϩ /Ca 2ϩ exchange current (I NCX ) are major inward currents that shape the cardiac action potential (AP). Previously, the profile of these currents during the AP was determined from voltage-clamp experiments that used Ca 2ϩ buffer. In this study, we aimed to obtain direct experimental measurement of these currents during cardiac AP with Ca 2ϩ cycling.
Introduction
The L-type Ca 2ϩ current (I Ca,L ) and the Na ϩ /Ca 2ϩ exchange current (I NCX ) are 2 major inward currents that provide the depolarization drive to shape the action potential (AP) plateau and the repolarization phase in cardiac myocytes. Changes in the magnitude or timing of these currents could cause development of cardiac arrhythmias. Hence, understanding the dynamic properties of these currents during the AP cycle is of great interest. However, the current knowledge on I Ca,L and I NCX during the AP has been largely based on model simulations derived from traditional voltage-clamp data. Previous voltage-clamp experiments often used simplified ionic solutions to isolate the currents and used exogenous Ca 2ϩ buffer-conditions that differ from the physiological milieu. In this study, we directly measured the ionic currents during the AP under a triad of conditions mimicking the physiological environment: (1) the cell's own AP was recorded and used as command voltage to directly record the I Ca,L and I NCX during the AP; (2) the physiological ionic compositions were used in both the internal and the external solutions; and (3) the intracellular Ca 2ϩ cycling during the AP was preserved by not using exogenous Ca 2ϩ buffer in the internal solution. We recorded the nifedipine-sensitive current (I NIFE ), which is the composite current of I Ca,L and I NCX , during the AP with Ca 2ϩ cycling. Then, we used a newly developed AP-clamp sequential dissection technique ("onion peeling") 1 to separate I Ca,L and I NCX by using nifedipine and SEA0400. This novel experimental approach allows us, for the first time, to directly visualize the dynamics of I Ca,L and I NCX during the AP with Ca 2ϩ cycling in the cell. Our data reveal novel and distinctive features of I Ca,L and I NCX that occur when the cell is most vulnerable to early or delayed afterdepolarizations. Measurement of the currents during the AP with Ca 2ϩ cycling under physiological conditions also provides realistic data to aid computational modeling and rational design of effective drug therapies for treating cardiac arrhythmias.
Methods
All laboratory procedures conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.
Cell isolation
Hartley guinea pigs (male, 3-4 months old, purchased from Charles River Laboratories, USA) were first injected with heparin (800 u, intraperitoneally) and then anesthetized with nembutal (100 mg/kg, intraperitoneally). After achieving deep anesthesia to suppress spinal cord reflexes, a standard enzymatic technique was used to isolate ventricular myocytes.
2 Electrophysiology AP-clamp sequential dissection experiments were conducted as described in our previous publication. 1 Cells were continuously superfused with a modified Tyrode solution (BTy) containing (in mmol/L) NaCl 120, KCl 5, CaCl 2 2, MgCl 2 1, 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) 10, NaHCO 3 25, glucose 10, pH 7.3. The pipette solution contained (in mmol/L) K-Aspartate 115, KCl 45, Mg-ATP 3, HEPES 5, Adenosine 3=,5=-cyclophosphate (cAMP) 0.1, pH 7.25. Depending on the experiment, 0, 2, or 10 mM Ethylene glycol-bis(2-aminoethylether)-N,N,N=,N=-tetraacetic acid (EGTA) was added into the pipette solution. The basic experimental steps were as follows: (1) Record the steady-state AP under the I clamp (I ϭ 0) at 1-Hz pacing frequency. (2) Apply this AP as the voltage command onto the same cell under the V clamp at 1 Hz. The net current output, I BG , should be zero. (3) Isolate the current of interest by using its specific blocker to remove it from the net current output, I drug . (4) The current of interest is then obtained by subtraction: I ϭ I BG Ϫ I drug . (5) Next, isolate the 2nd current of interest by applying the 2nd channel blocker, and then obtain the 2nd current by subtraction: I 2 ϭ I drug1 Ϫ I drug2 . Repeat step 5 to isolate the 3rd, the 4th, and more currents by sequentially adding the specific blocker for each channel (Table 1) . The currents were recorded after they reached steady state. The inhibitory coefficient of SEA0400 on blocking I NCX was measured by using a standard ramp V-clamp protocol. 3 The inhibitory coefficient of SEA0400 on blocking I Ca,L was measured by using a standard V-clamp protocol. 2 All experiments were conducted at 21°C Ϯ 1°C, except those in Figure 6 , which were conducted at 36°C Ϯ 0.5°C. Chemicals were purchased from Sigma-Aldrich, USA, except SEA0400, 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline, which was provided by Taisho Pharmaceutical (Tokyo, Japan).
Results

Nifedipine-sensitive current during the AP with Ca
2؉ cycling
Ionic currents were recorded in ventricular cardiac myocytes by using the onion-peeling technique. First, we tested the effect of 0.1% Dimethyl sulfoxide; C 2 H 6 OS (DMSO), which is used as a solvent of drugs. Application of DMSO resulted in no change in the zero baseline current ( Figure  1A ). Nifedipine at 10 M concentration was added into the bath to dissect out I NIFE , as shown in Figure 1B . I NIFE displays several distinct features. There is a steep rise in the current at phase 1 of the AP, which we named the initial current ("I") and measured it at 10 ms following the AP upstroke. During phase 2, the current slows down and forms a dome, which we named the dome current and measured it at APD10 (early plateau "E") and APD20 (dome "D") (APD# is defined as the AP duration measured at #% repolarization.) During phase 3, the current declines but then resurges to reach a second dome ("S"). Then, the current declines again and slowly diminishes during phase 4; we named this feature the residual current ("R") and measured it at 30 ms after ϪV max (the maximum repolarization rate of the AP during phase 3). While the initial phase and the dome features were seen before, 4,5 the second dome and the residual current during AP phases 3 and 4 are novel observations that had not been reported previously.
To confirm that I NIFE originates from blocking the L-type Ca 2ϩ channel, we used a different blocker, nisoldipine 1 M, to record the nisoldipine-sensitive current (I NISO ) under the AP clamp. I NISO ( Figure 1C , n ϭ 8 cells) displays the same distinct features and similar values as I NIFE ( Figure  1D , n ϭ 8 cells).
Corresponding to the residual current, we also found a slowing down of the membrane repolarization at the end of the AP that extends beyond APD95 ( Figure 1E ), which we named residual depolarization and measured it as the voltage above the resting potential at 30 ms after ϪV max (the same time point for measuring the residual current). The residual depolarization had not been reported in the literature. However, we have consistently found this residual depolarization in both the single cell and the ventricular tissue (using sharp electrode recording of the AP, data not shown), confirming its existence in vivo. Furthermore, the Figure 1F ), indicating a connection between the 2.
I NIFE consists of I Ca,L and I NCX
I NIFE is composed of not only I Ca,L but also I NCX and other Ca 2ϩ -sensitive currents. This is because blocking I Ca,L also eliminates the entry of Ca 2ϩ into the cell to trigger sarcoplasmic reticullum (SR) Ca 2ϩ release, which abolishes the intracellular Ca 2ϩ transient and its associated currents such as the inward I NCX , the Ca 2ϩ -activated Cl Ϫ current, and possibly a fraction of K ϩ currents that is sensitive to Ca 2ϩ . We conducted all experiments at 21°C to render the Cl Ϫ current negligible. 6, 7 To determine the Ca 2ϩ sensitivity of K ϩ currents, we used the onion-peeling method 1 to record I Ks , I Kr , I K1 , and I NIFE in the same cell. The currents measured with Ca 2ϩ cycling versus with EGTA are listed in Table 1 . I K1 and I Ks did not show any significant difference in the peak current density; peak I Kr decreased slightly (0.15 A/F). However, the average peak current of I NIFE was 1.4
A/F with Ca 2ϩ cycling and 2.4 A/F with EGTA. Hence, the Ca 2ϩ -sensitive component in K ϩ currents is much smaller than the magnitude of I NIFE , which should cause only a slight underestimation of I NIFE . Therefore, the I NIFE recorded in our experiment is mainly composed of I Ca,L and I NCX .
Ca
2؉ -dependent features of I NIFE
To separate the I Ca,L and I NCX components in I NIFE , we added 10 mM EGTA to the pipette solution to buffer intracellular Ca 2ϩ and minimize the inward I NCX . A typical recording of I NIFE with 10 mM EGTA is shown in Figure  2A . Now the I NIFE profile displays the initial current and the dome current features, but without any discernable second dome and residual current, different from that recorded with Ca 2ϩ cycling ( Figure 1B) . Moreover, the residue depolarization is also eliminated ( Figure 2B ).
When EGTA concentration in the pipette was reduced from 10 to 2 mM, I NIFE displayed the initial current and the dome current but the second dome was absent in all records. Buffering of Ca 2ϩ eliminated the second dome and the residual current but elevated the dome current in a concentration-dependent manner (Figure 2A and 2C). These phenomena are visualized in the I-V relationship ( Figure 2D ) and confirmed in the statistical comparison of the current amplitudes along the AP time course ( Figure 2E ). Again, corresponding to a lack of the residual current the residual depolarization was also eliminated ( Figure 2F ). Note that low EGTA (2 mM) buffering can significantly affect Ca 2ϩ and the dynamics of I NIFE during AP.
Contribution of I NCX to I NIFE
The fact that buffering Ca 2ϩ can eliminate the second dome and the residual current suggests that I NCX might contribute to these features. To investigate this, we used an I NCX inhibitor, SEA0400 at 3 M concentration, to record the SEA-sensitive current (I SEA ). As shown in Figure 3A , I SEA displays a small initial current at AP phase 1; gradually increases during phase 2, peaks at early phase 3 and declines; the current then turns around and reaches the second dome at late phase 3; and then declines to a residual current extending into phase 4. These data show that I NCX dominates the late phases of AP. After I SEA had developed and stabilized, we added 10 M of nifedipine into the bath and recorded the I SEA ϩ NIFE current ( Figure 3B and 3C ). Statistical comparison of the currents shows that the contribution of I NCX to I SEA ϩ NIFE is relatively small during the early phases of AP but becomes larger in later phases ( Figure 3D ).
Although SEA0400 is the most potent inhibitor of I NCX currently available, it also partially blocks I Ca,L . This means that I SEA is composed of not only I NCX but also a small portion of I Ca,L . To separate I NCX from I Ca,L , we measured the inhibitory coefficients of 3 M SEA0400 on I NCX and I Ca,L , respectively. The inhibitory effect of SEA0400 on I NCX is voltage dependent, about 65% and 51% for the outward I NCX measured at ϩ30 mV and the inward I NCX measured at Ϫ75 mV ( Figure 3E and  3F) . The inhibitory effect of 3 M SEA0400 on I Ca,L is concentration. However, currently there is no available technique to directly measure the local Ca 2ϩ concentrations sensed by the channel/transporter. To circumvent this problem, we took a simple approach to calculate I Ca,L and I NCX from the paired recordings of I SEA and I SEA ϩ NIFE (using 2 equations to solve for 2 unknowns) by utilizing the differential inhibitory coefficients of SEA versus nifedipine. This simple calculation using paired recordings provides a somewhat direct approach to disentangle I Ca,L and I NCX . Given that I Ca,L and I NCX are the predominant currents blocked by nifedipine and SEA0400, the charge conservation gives the following equations:
where k CaL and k NCX are the voltage-dependent inhibitory coefficients of I Ca,L and I NCX measured from the voltageclamp experiments shown in Figure 3F and 3H. ␣ is a scaling factor (ranging between 0 and 1 inclusive) that reflects the portion of I NCX that is affected by changes in I Ca,L . Because the local Ca 2ϩ concentration sensed by the Na ϩ /Ca 2ϩ exchanger is unknown, we solved the equations for ␣ ϭ 0 and 1 to calculate the boundary conditions and estimate the currents. Figure 4 shows I NCX and I Ca,L computed from paired recordings of I SEA and I SEA ϩ NIFE during the AP with Ca 2ϩ cycling (column A) or with EGTA (column B). The current traces are shown in the upper row. Notice that I SEA is an inward current due to the forwardmode I NCX when Ca 2ϩ is cycling but turns into an outward current due to the reverse-mode I NCX when Ca 2ϩ is buffered with 10 mM EGTA. The I Ca,L and I NCX calculated from I SEA and I SEA ϩ NIFE are shown in Figure 4 (middle and lower row). The blue (␣ ϭ 1) and red (␣ ϭ 0) traces demarcate the upper and the lower boundaries of the currents, respectively. The actual current should fall within the Notice an absence of the second dome, the residual current (A), and the residual depolarization (B). I NIFE recorded with 2 mM EGTA (C, n ϭ 14 cells), the currentvoltage relationship (D), and statistical comparison between different Ca 2ϩ buffering conditions (E) show increased current density with more EGTA buffering. Panel F demonstrates that EGTA did not affect the voltage at -V max but significantly reduced the residual depolarization at 30 ms after -V max (t test, *P Ͻ.05; **P Ͻ.01). AP, action potential; I NIFE , nifedipine-sensitive current.
boundaries. Note that I NCX is bounded within a narrow range; hence, the profile of I NCX during the AP is clearly defined. A probable profile of the current is highlighted with a black line (calculated as an intermediate state with ␣ ϭ 0.8).
The magnitude of I Ca,L dome current is about 0.3 A/F when Ca 2ϩ is normally cycling (column A, middle panel) but becomes much greater to about 2 A/F when Ca 2ϩ is buffered (column B, middle panel). This difference reflects a profound influence of the Ca 2ϩ -dependent inactivation (CDI) of I Ca,L . Note also that buffering Ca 2ϩ completely eliminated the second dome and the residual current. When Ca 2ϩ is cycling, I NCX is briefly outward at the beginning of AP but soon becomes an inward current (column A, lower panel) and reaches a peak of about 0.2 A/F. In contrast, when Ca 2ϩ is buffered, I NCX is always outward during the AP (column B, lower panel).
Effects of SEA0400
It has been proposed that inhibiting I NCX might provide an effective therapy for some forms of arrhythmias. We predicted that using SEA0400 to treat the cell would reduce the dome current and the residual current. To test this, we pretreated cells with 3 M SEA0400 and recorded the remaining I NIFE under the AP clamp. As shown in Figure 5A , SEA0400 treatment shortened APD, consistent with its effect on reducing the dome and the residual current.
A representative trace of the I NIFE in the SEA0400-pretreated cell is shown in Figure 5B . Recall that in the control cell ( Figure 1B ) the dome is larger than the initial current; here, in the SEA0400-pretreated cell the dome becomes smaller than the initial current, indicating that a portion of the dome current is contributed by the inward I NCX . The residual current is significantly smaller after SEA0400 treatment ( Figure 5C ), consistent with the I NCX contribution. Meanwhile the residual depolarization is also smaller ( Figure 5D ). In fact, a positive correlation between the residual current and the residual depolarization exists universally for all the experimental conditions tested (Figure 5E) , indicating that the residual current is responsible for the residual depolarization.
I NIFE at body temperature
To establish the physiological relevance of our new findings, we also conducted AP-clamp experiments at body temperature. The I NIFE at 36 o C displays essentially the same features ( Figure 6A ). The second dome and the residual currents are prominent, and the residual depolarization is also present ( Figure 6B ). The insert shows the Ca 2ϩ transient measured with Fura-2. Using EGTA to buffer Ca 2ϩ eliminates the residual current ( Figure 6C ) and the residual depolarization ( Figure 6D ). Statistical comparison shows that with Ca 2ϩ cycling, the dome current is significantly smaller ( Figure 6E ) due to the CDI of I Ca,L , but the residual current and the residual depolarization are significantly larger ( Figure 6E and 6F) due to the inward I NCX .
Discussion
Here we present experimental measurements of I Ca,L and I NCX currents during the AP with Ca 2ϩ cycling in ventricular myocytes. This was enabled by a triad of conditions: (1) using the cell's own AP as the voltage command; (2) using the internal and external solutions that mimic the physiological milieu; and (3) preserving Ca 2ϩ cycling during the AP by not using exogenous Ca 2ϩ buffer. To the best of our knowledge, it is the first time that this triad of conditions has been used to record the ionic currents during cardiac AP with Ca 2ϩ cycling. I NIFE was obtained by blocking L-type Ca 2ϩ current under the AP clamp. However, blocking Ca 2ϩ current also affects other Ca 2ϩ -dependent currents including I NCX , Ca 2ϩ -activated Cl Ϫ current, and the Ca 2ϩ -sensitive components in K ϩ currents. The Cl Ϫ current was rendered negligible by conducting experiments at 21 o C. 6, 7 We also found no significant contributions of K ϩ currents. Hence, I NIFE mainly consists of I Ca,L and I NCX . The profile of I NIFE during the AP exhibits distinct features: an initial current at phase 1, a dome at phase 2, a resurging second dome at phase 3, and a residual current at phase 4. The second dome and the residual current had not been reported before; these novel features become apparent only when Ca 2ϩ is not buffered. We also detected a hitherto unreported residual Current and Na ϩ /Ca 2ϩ Exchange Current During Action Potential depolarization at the end of the AP that can be attributed to the residual current. Furthermore, we found that I Ca,L contributes predominantly to the initial and the dome current whereas I NCX contributes significantly to the second dome and the residual current. The timing and magnitude of these currents suggest their relative roles in shaping the AP profile and generating early or delayed afterdepolarizations. The dynamic profile of I Ca,L during cardiac AP and its contribution to afterdepolarizations has been under active investigation. Previous studies used variants of the APclamp technique and reported the initial current and the dome current features but never before reported the second dome and the residual current features. This discrepancy can be explained by the experimental conditions used in those studies, which differed from the triad of conditions used in our experiments. First, in earlier studies the AP waveform used as voltage command was either a representative AP 5 or a constructed AP, 8 which does not, in general, match each cell's unique AP. Hence, the current profile would be distorted from its natural state in the cell. Second, earlier experiments used nonphysiological solutions (substituting Na ϩ and K ϩ ), but ion species and concentration are known to alter the Ca 2ϩ channel kinetics. 9, 10 Third, most earlier experiments used exogenous Ca 2ϩ buffer, and the I Ca,L profile reported in those studies is similar to the I NIFE profile recorded with EGTA in our study (Figure 2A and 2C) . The second dome and the residual current in I NIFE are novel features revealed only under the triad of conditions used in our AP-clamp experiments.
The dynamic profile of I Ca,L during the AP is determined by an interplay between the changing driving force during the AP and CDI. Importantly, our data show a significant modulation of I Ca,L during the AP by CDI, seen as the I NIFE dome current increases with EGTA in a dose-dependent manner ( Figure 2E) . The average dome current is 1.4 pA/pF when Ca 2ϩ is cycling, and this increases to 2.4 pA/pF when Ca 2ϩ is buffered with 10 mM EGTA. It is noteworthy that previous voltage-clamp and AP-clamp studies (using Ca 2ϩ buffer) reported a peak I Ca,L between 2 and 10 pA/pF; quantitative models based on those data also had a peak I Ca,L in that range. 11 Our data show a much smaller I Ca,L magnitude in the cell measured under the AP clamp with Ca 2ϩ cycling and provide realistic experimental data for future modeling considerations.
Figure 5
Using 3 M SEA0400 to treat cells shortened the AP duration (A) and reduced I NIFE (B). The residual current (C) and the residual depolarization (D) were significantly reduced (n ϭ 7 cells, t test, *P Ͻ.05), demonstrating a predominant influence of I NCX on these features. Panel E shows a universal correlation (r ϭ 0.917) between the magnitude of residual current and residual depolarization under all experimental conditions tested. AP, action potential; I NCX , Na ϩ /Ca 2ϩ exchange current; I NIFE , nifedipine-sensitive current.
Previously, a lack of a selective blocker prevented direct measurement of I NCX.
12 In this study, we used SEA0400 paired with nifedipine to isolate the I NCX during the AP with Ca 2ϩ cycling. Our data reveal that I NCX presents an outward current at the beginning of the AP, which turns into a small inward current at early phase 2; the inward I NCX increases and contributes significantly to the I NIFE second dome and the residual current at phases 3 and 4. In comparison to earlier studies, Grantham and Cannell 5 had calculated an I NCX profile that showed a large outward current throughout AP phases 1 and 2, then turned into an inward current at phase 3, and then peaked at the end of phase 3. Weber et al 13 reconstructed the I NCX during the AP by correlating the Ca 2ϩ transient with the steady-state I NCX measurements at various Ca 2ϩ concentrations. They showed in rabbit ventricular myocytes that I NCX was a rapid outward current at phase 1, turned to inward at early phase 2, reached a peak at the end of phase 3, and then slowly declined during phase 4. The I NCX profile in Figure 4 (column A, lower panel) shows similar features as their result but differs in the time course and the magnitude of current. Given the importance of I NCX in shaping the AP, our AP-clamp measurement of I NCX in the physiological milieu provides important data for developing more accurate quantitative models.
Increased I Ca,L or I NCX had been found to induce afterdepolarizations. 14, 15 Inhibiting I Ca,L with Ca 2ϩ channel-blocker effectively eliminated early afterdepolarizations. 14, 16, 17 Inhibiting I NCX with SEA0400 also effectively reduced early and delayed afterdepolarizations. 3, 12 Hence, I Ca,L and I NCX have been proposed as therapeutic targets for treating cardiac arrhythmias (see review by Sipido et al 12 ). The relative contributions of I Ca,L and I NCX to the depolarization drive are resolved in the current study. As we observed, I Ca,L is the dominant inward current during AP phases 1 and 2, whereas I NCX is the dominant inward current during phases 3 and 4. Both I Ca,L and I NCX contribute to the dome current, the second dome, and the residual current. Given the intertwined nature of I Ca,L and I NCX , it is the combination of these 2 currents, not just one or the other, that determines the total depolarization drive that shapes the AP profile and afterdepolarizations. 18 Importantly, the newly observed second dome and the residual . Panels E and F show the mean Ϯ SE and statistical comparison at the features points (t test, **P Ͻ.01, ***P Ͻ.001). AP, action potential; I NIFE , nifedipine-sensitive current.
